AbbVie beats quarterly revenue estimates, raises earnings forecast
AbbVie’s first-quarter revenue beat analysts’ estimates on Thursday on higher sales of its rheumatoid arthritis drug Humira and cancer treatment Imbruvica, while raising full-year earnings forecast. The company’s net revenue rose 21.4 percent to $7.93 […]